Pricing Log in Create free account

Lakewood-Amedex Biotherapeutics Inc. (LABT) vs Atrinsic Inc. (PTIX)

Lakewood-Amedex Biotherapeutics Inc. and Atrinsic Inc. are both Biotechnology companies. Lakewood-Amedex Biotherapeutics Inc. and Atrinsic Inc. are of similar size ($1.3M and $1.3M). Lakewood-Amedex Biotherapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.2×. Across the 9 metrics below, Lakewood-Amedex Biotherapeutics Inc. leads on 5 and Atrinsic Inc. on 4.

Valuation

Metric LABT PTIX Biotechnology median
P/E n/m 0.24 10.60
P/S n/m n/m 9.40
P/B 0.12 0.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.71 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (2,135.14%) 412.96% (32.88%)
Free cash flow yield (934.12%) (220.47%) (23.13%)

Profitability

Metric LABT PTIX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (338.24%) (51.96%)
Return on assets (302.50%) 378.63% (46.06%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric LABT PTIX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 15.32% 188.24% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LABT PTIX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.70 0.66 4.97
Net debt to EBITDA 0.06 0.52 1.01

Dividend

Metric LABT PTIX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LABT PTIX Biotechnology median
Market cap 1.27m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack